Quadria Capital
People
Quadria Capital hires former Investcorp exec to beef up India investment team
Quadria Capital, a healthcare-focused private equity firm that finished raising its third fund earlier this year, has hired a former ......
Healthcare
HealthKois' Ajay Mahipal on new fund's investment thesis, return expectations and more
Healthcare-focused investment firm HealthKois, which is led by the team that managed HealthQuad funds I and II, is on track ......
General
Grapevine: Oxyzo, Quadria Capital, Quest Global, Continuum Green Energy, others in news
Lending firm Oxyzo Financial Services is seeking to raise fresh primary capital ahead of its planned initial public offering (IPO), ......
General
Grapevine: WestBridge, Edelweiss MF, Quadria, Encube Ethicals, NCDEX in news
WestBridge Capital is close to striking a minority stake deal in Edelweiss Mutual Fund, and Quadria Capital is planning to ......
Healthcare
Bottomline: Global expansion boosts PE-backed Nephroplus's revenue, margins
Bessemer and Quadria Capital-backed Nephrocare Health Services, which operates dialysis centers under the Nephroplus brand, has recorded significant improvement in ......
Healthcare
Deals Digest: PE firms swing in action but M&As remain tepid
Deal activity in India picked up in the week gone by as several private equity firms struck transactions across healthcare, technology ......
Healthcare
Outlook 2025: How dealmaking in healthcare sector may pan out this year
India’s healthcare sector is likely to record another busy year of dealmaking with several companies planning to go public in ......
General
Grapevine: TVS Credit, Avendus, Haldiram, Aragen, Yotta in news
Another investor has joined the race to buy KKR's stake in Avendus, while a top US-based private equity firm is ......
General
Grapevine: Zepto, Quadria, TPG, Mensa Brands in news
Quick commerce startup Zepto is in talks to raise $100-150 million (Rs 840-1,260 crore) from domestic family offices and high-net-worth individuals at ......
General
Grapevine: Aragen Life, Urban Company investors weigh stake sale
Promoters and investors in Aragen Life Sciences, the Goldman Sachs-backed contract research organisation (CRO), plan to sell a 10% stake in a ......